期刊文献+

2型糖尿病患者PPARα基因多态性的研究 被引量:4

Study on Peroxisome Proliferator-activated Receptor-α(PPAR α) Gene Polymorphism in Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的 :探讨过氧化物酶体增殖物激活受体α(PPARα)基因第 5外显子L16 2V(CTT→GTT)多态性与 2型糖尿病 (T2DM )的关系。方法 :采用多聚酶联反应 限制性片段长度多态性 (PCR RFLP)的方法对湖北地区 10 0例T2DM患者及 80例正常对照者PPARα基因L16 2V多态性进行研究。结果 :在T2DM患者和正常对照者中未发现PPARα基因L16 2V变异。结论 :PPARα基因L16 2V多态性与湖北地区T2DM不相关。 Objective: To investigate the peroxisome proliferator-activated receptor- α (PPAR α ) gene L162V(CTT→GTT) polymorphism and its relationship with type 2 diabetes mellitus(T2DM). Methods: PPAR α gene L162V polymorphism was assayed by polymerase chain reaction(PCR)-restriction fragment length polymorphism (RFLP) between 100 T2DM and 80 controls in Hubei . Results: Both in T2DM group and control group,PPAR α gene L162V polymorphism was not detected. Conclusion: The results suggest that the L162V polymorphism of PPAR α gene is not associated with T2DM in Hubei population.
出处 《武汉大学学报(医学版)》 CAS 2004年第4期459-461,共3页 Medical Journal of Wuhan University
基金 湖北省自然科学基金资助项目 (2 0 0 2AB14 3 )
关键词 PPARα基因 多态性 2型糖尿病 PPAR α gene polymorphism type 2 diabetes mellitus
  • 相关文献

参考文献10

  • 1Vohl M C, Lepage P, Gaudet D, et al. Molecular scanning of the human PPARα gene : association of L162V mutation with hyperapobetalipoproteinemia. J of Lipid Research, 2000,41 (6): 945
  • 2Flavell DM, Pineda Torra I, Jamshidil Y, et al. Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type Ⅱ diabetic subjects. Diabetologia, 2000, 43(5): 673
  • 3Lacquemnat C, Lepretre F, Pinend Torre I, et al. Mutation screening of the PPARα gene in type 2 diabetes association with coronary heart disease. Diabetes & Metabolism (Paris) ,2000,26(4) :393
  • 4Evans D, Aberle J, Wendt D, et al. A polymorphism,L162V, in the peroxisome proliferator-activated receptorα(PPARα) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J Mol Med, 2001, 79(4):198
  • 5Schoonjans K, Martin B, Staels B, et al. Peroxisome proliferator-activated receptors, orphans with ligands andfunction. Curr Opin Lipidol,1997,8(3) :159
  • 6Schoonjans K, Staels B, Auwerx J. Peroxisome proliferator-activated receptors(PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta, 1996, 1 302(1):93
  • 7Schoonjans K, Staels B, Auwerx J. Role of the Peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene erpression. J Lipid Res, 1996,37(4) :907
  • 8Torra IP, Gervios P, Staels B. Peroxisome proliferatoractivated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol, 1999,10(2):151
  • 9Staels B, Dallongeville J, Auwerx K, et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism.Circulation, 1998,98 (9): 2 088
  • 10Devchand PR, Keller H, Peters JM, et al. The PPARαleukotriene B4 pathway to inflammation control. Nature,1996,384(6 604) :39

同被引文献34

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部